Deepinder Dhaliwal, AAO 2018 – DMEK and DWEK for Fuchs’ dystrophy (part 2 of 2)
In part 2 of her interview, Dr Deepinder Dhaliwal describes which patients make ideal candidates for descemetorhexis without endothelial keratoplasty (DWEK), and those that are contraindicated. Dr Dhaliwal also explains why some studies may have reported poor outcomes with DWEK. Reasons such as failure to provide rho kinase inhibitors as part of the post-operative management, or those with advanced corneal disease.
Questions:
1. Which patients are best suited to treatment with descemetorhexis without endothelial keratoplasty (DWEK) and what are the contraindications? (0:11)
2. Why have some studies reported poor outcomes for DWEK? (1:05)
Speaker disclosures: Deepinder Dhaliwal has nothing to disclose in relation to this interview.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.